During the past decade, Nashville Breast Center conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 5 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nashville Breast Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 4 trials, followed by "Agendia" with 3 trials sponsored, "National Cancer Institute (NCI)" with 3 trials sponsored, "Intact Medical Corporation" with 1 trials sponsored and "Juva Life" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nashville Breast Center" #1 collaborator was "National Cancer Institute (NCI)" with 5 trials as a collaborator, "American College of Surgeons" with 1 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator, "Cancer and Leukemia Group B" with 1 trials as a collaborator and "NCIC Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Nashville Breast Center" are "Breast Cancer" (7 trials), "Stage II Breast Cancer" (3 trials), "Stage IIIA Breast Cancer" (3 trials), "Breast Neoplasms" (2 trials) and "Anxiety" (1 trials). Many other conditions were trialed in "Nashville Breast Center" in a lesser frequency.

Most popular intervention types in "Nashville Breast Center" are "Other" (10 trials), "Drug" (8 trials), "Procedure" (3 trials), "Device" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (3 trials), "placebo" (3 trials), "Anastrozole" (2 trials), "Exemestane" (2 trials) and "Letrozole" (2 trials). Other intervention names were less common.

The vast majority of trials in "Nashville Breast Center" are 12 trials for "Female" genders and 7 trials for "All" genders.

Currently, there are NaN active trials in "Nashville Breast Center". undefined are not yet recruiting, 2 are recruiting, 6 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 7 completed trials in Nashville Breast Center, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Nashville Breast Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".